Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Circulating antigen: bad or good for immunoscintigraphy?

M V Pimm

    Nuclear Medicine and Biology
    |February 1, 1995
    PubMed
    Summary
    This summary is machine-generated.

    Circulating antigen hinders radiolabeled antibody tumor targeting in mice but not humans, despite immune complex formation. This difference in antibody-antigen complex handling warrants further investigation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Carrier design: new generation of polycationic branched polypeptides containing OH groups with prolonged blood survival and diminished in vitro cytotoxicity.

    Bioconjugate chemistry·1999
    Same author

    Synthesis, conformation, biodistribution, and hormone-related in vitro antitumor activity of a gonadotropin-releasing hormone antagonist-branched polypeptide conjugate.

    Bioconjugate chemistry·1996
    Same author

    Biodistribution in tumour-bearing mice of polycationic, amphoteric and polyanionic branched polypeptides with a poly(L-lysine) backbone labelled with 125I and 111In: tumour accumulation less than that of labelled serum proteins.

    Journal of cancer research and clinical oncology·1996
    Same author

    Gamma scintigraphy of the biodistribution of 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in mice with transplanted melanoma and mammary carcinoma.

    Journal of drug targeting·1996
    Same author

    Gamma scintigraphy of a 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugate containing galactosamine following intravenous administration to nude mice bearing hepatic human colon carcinoma.

    Journal of drug targeting·1996
    Same author

    Gamma scintigraphy of 111In-labelled branched chain polypeptides (BCP) with a poly(L-lysine) backbone in mice with mammary carcinoma: effect of charge on biodistribution and tumour imaging potential.

    Annals of nuclear medicine·1995

    Area of Science:

    • Oncology
    • Immunology
    • Radiopharmaceuticals

    Background:

    • Circulating antigens can impede radiolabeled murine monoclonal antibody (mAb) localization in human tumors xenografted in mice due to immune complex formation.
    • This phenomenon, observed in animal models, is surprisingly absent in human patients with circulating antigens, where immunoscintigraphy remains effective.

    Purpose of the Study:

    • To investigate the discrepancy in the effect of circulating antigen on antibody-antigen complex behavior between mouse models and human patients.
    • To explore the implications of this dichotomy for immunoscintigraphy and patient selection.

    Main Methods:

    • Review of existing evidence on radiolabeled mAb behavior in the presence of circulating antigens in both murine xenograft models and human patients.
    • Analysis of immune complex formation and its impact on tumor imaging sensitivity.

    Related Experiment Videos

    Main Results:

    • In mice, circulating antigen formation of immune complexes significantly restricts mAb tumor localization.
    • In humans, immune complexes form but do not compromise immunoscintigraphy; circulating antigen levels can positively correlate with imaging sensitivity.
    • The species of the antibody (murine vs. human/chimeric) interacting with the antigen may influence complex handling.

    Conclusions:

    • A significant difference exists in how circulating antigen-mediated immune complexes affect antibody tumor targeting between mice and humans.
    • The use of chimeric or human mAbs in clinical settings may alter the relevance of current murine models.
    • Further research is crucial to understand the underlying mechanisms of this species-specific difference and its clinical implications for immunoscintigraphy.